BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 9776361)

  • 1. SB-224289--a novel selective (human) 5-HT1B receptor antagonist with negative intrinsic activity.
    Selkirk JV; Scott C; Ho M; Burton MJ; Watson J; Gaster LM; Collin L; Jones BJ; Middlemiss DN; Price GW
    Br J Pharmacol; 1998 Sep; 125(1):202-8. PubMed ID: 9776361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The selective 5-HT1B receptor inverse agonist 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo.
    Gaster LM; Blaney FE; Davies S; Duckworth DM; Ham P; Jenkins S; Jennings AJ; Joiner GF; King FD; Mulholland KR; Wyman PA; Hagan JJ; Hatcher J; Jones BJ; Middlemiss DN; Price GW; Riley G; Roberts C; Routledge C; Selkirk J; Slade PD
    J Med Chem; 1998 Apr; 41(8):1218-35. PubMed ID: 9548813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'methyl-4'-(5-methyl-1,2,3-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): a novel, potent and selective 5-HT1B receptor antagonist.
    Scott C; Langmead CJ; Clarke KL; Wyman P; Smith PW; Starr KR; Dawson LA; Price GW; Hagan JJ; Watson J
    Neuropharmacology; 2006 Jun; 50(8):984-90. PubMed ID: 16546225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-HT1B receptor-mediated contractions in human temporal artery: evidence from selective antagonists and 5-HT receptor mRNA expression.
    Verheggen R; Hundeshagen AG; Brown AM; Schindler M; Kaumann AJ
    Br J Pharmacol; 1998 Aug; 124(7):1345-54. PubMed ID: 9723944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological analysis of G-protein activation mediated by guinea-pig recombinant 5-HT1B receptors in C6-glial cells: similarities with the human 5-HT1B receptor.
    Pauwels PJ; Wurch T; Palmier C; Colpaert FC
    Br J Pharmacol; 1998 Jan; 123(1):51-62. PubMed ID: 9484854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and serotonergic activity of 3-[2-(pyrrolidin-1-yl)ethyl]indoles: potent agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B receptor.
    Sternfeld F; Guiblin AR; Jelley RA; Matassa VG; Reeve AJ; Hunt PA; Beer MS; Heald A; Stanton JA; Sohal B; Watt AP; Street LJ
    J Med Chem; 1999 Feb; 42(4):677-90. PubMed ID: 10052975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SB-236057, a selective 5-HT1B receptor inverse agonist, blocks the 5-HT human terminal autoreceptor.
    Middlemiss DN; Göthert M; Schlicker E; Scott CM; Selkirk JV; Watson J; Gaster LM; Wyman P; Riley G; Price GW
    Eur J Pharmacol; 1999 Jun; 375(1-3):359-65. PubMed ID: 10443589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue.
    Scott C; Soffin EM; Hill M; Atkinson PJ; Langmead CJ; Wren PB; Faedo S; Gordon LJ; Price GW; Bromidge S; Johnson CN; Hagan JJ; Watson J
    Eur J Pharmacol; 2006 Apr; 536(1-2):54-61. PubMed ID: 16571351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro characterization of AR-A000002, a novel 5-hydroxytryptamine(1B) autoreceptor antagonist.
    Ahlgren C; Eriksson A; Tellefors P; Ross SB; Stenfors C; Malmberg A
    Eur J Pharmacol; 2004 Sep; 499(1-2):67-75. PubMed ID: 15363952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological diversity between native human 5-HT1B and 5-HT1D receptors sited on different neurons and involved in different functions.
    Marcoli M; Maura G; Munari C; Ruelle A; Raiteri M
    Br J Pharmacol; 1999 Feb; 126(3):607-12. PubMed ID: 10188970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SB-216641 and BRL-15572--compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors.
    Price GW; Burton MJ; Collin LJ; Duckworth M; Gaster L; Göthert M; Jones BJ; Roberts C; Watson JM; Middlemiss DN
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):312-20. PubMed ID: 9303567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional effects of the muscarinic receptor agonist, xanomeline, at 5-HT1 and 5-HT2 receptors.
    Watson J; Brough S; Coldwell MC; Gager T; Ho M; Hunter AJ; Jerman J; Middlemiss DN; Riley GJ; Brown AM
    Br J Pharmacol; 1998 Dec; 125(7):1413-20. PubMed ID: 9884068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of h5-HT1B receptor selectivity for 5-HT terminal autoreceptor activity: an in vivo microdialysis study in the freely-moving guinea-pig.
    Roberts C; Price GW; Gaster L; Jones BJ; Middlemiss DN; Routledge C
    Neuropharmacology; 1997; 36(4-5):549-57. PubMed ID: 9225280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How efficacious are 5-HT1B/D receptor ligands: an answer from GTP gamma S binding studies with stably transfected C6-glial cell lines.
    Pauwels PJ; Tardif S; Palmier C; Wurch T; Colpaert FC
    Neuropharmacology; 1997; 36(4-5):499-512. PubMed ID: 9225275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of selective h5-HT1B (SB-216641) and h5-HT1D (BRL-15572) receptor ligands on guinea-pig and human 5-HT auto- and heteroreceptors.
    Schlicker E; Fink K; Molderings GJ; Price GW; Duckworth M; Gaster L; Middlemiss DN; Zentner J; Likungu J; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):321-7. PubMed ID: 9303568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure to detect in vivo inverse agonism of the 5-HT(1B) receptor antagonist SB-224289 in 5-HT-depleted guinea-pigs.
    Stenfors C; Ross SB
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):462-7. PubMed ID: 12070760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoradiographic characterisation of [35S]GTPgammaS binding stimulation mediated by 5-HT1B receptor in postmortem human brain.
    Mostany R; Pazos A; Castro ME
    Neuropharmacology; 2005 Jan; 48(1):25-33. PubMed ID: 15617724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The selective 5-HT1B receptor inverse agonist SB-224289, potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo.
    Gaster LM; Ham P; Joiner GF; King FD; Mulholland KR; Wyman PA; Hagan JJ; Price GW; Roberts C; Routledge C; Selkirk J; Slade PD; Middlemiss DN
    Ann N Y Acad Sci; 1998 Dec; 861():270-1. PubMed ID: 9928285
    [No Abstract]   [Full Text] [Related]  

  • 19. h5-HT(1B) receptor-mediated constitutive Galphai3-protein activation in stably transfected Chinese hamster ovary cells: an antibody capture assay reveals protean efficacy of 5-HT.
    Newman-Tancredi A; Cussac D; Marini L; Touzard M; Millan MJ
    Br J Pharmacol; 2003 Mar; 138(6):1077-84. PubMed ID: 12684263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (+)-WAY 100135, a partial agonist, at native and recombinant 5-HT1B/1D receptors.
    Davidson C; Ho M; Price GW; Jones BJ; Stamford JA
    Br J Pharmacol; 1997 Jun; 121(4):737-42. PubMed ID: 9208142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.